Concordia International Corp Company Profile (TSE:CXR)

About Concordia International Corp (TSE:CXR)

Concordia International Corp logoConcordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. It operates through three segments: Concordia International, Concordia North America, and Orphan Drugs. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies. This segment’s products include Tetroxin drug for severe hypothyroid states; Macrobid/Macrodantin to treat bladder infections, such as cystitis and urinary tract infections; Fucithalmic, a topical gel treatment for patients suffering with a bacterial infection of the surface lining of the front of the eye; and Eltroxin, levothyroxine sodium that treats patients with an underactive thyroid gland. The Concordia North America segment provides Donnatalm, which is used as adjunctive therapy for irritable bowel syndrome; Plaquenil and Plaquenil AG to treat rheumatoid arthritis and manage the complications of lupus, as well as suppress acute attacks from certain strains of malaria; and Zonegran, an anti-seizure drug indicated for adjunctive therapy in the treatment of partial seizures in adults with epilepsy. The Orphan Drugs segment develops Photofrin, a light-based cancer treatment that combines a photosensitizing drug called porfimer sodium with a specific type of light to attack cancer cells. The company sells through direct sales and local partnerships. The company was formerly known as Concordia Healthcare Corp. and changed its name to Concordia International Corp. in 2016. Concordia International Corp. is headquartered in Oakville, Canada.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: TSE:CXR
  • CUSIP: N/A
  • Web: concordiarx.com
Capitalization:
  • Market Cap: C$80.72 million
  • Outstanding Shares: 51,089,000
Average Prices:
  • 50 Day Moving Avg: C$1.86
  • 200 Day Moving Avg: C$2.16
  • 52 Week Range: C$1.41 - C$12.46
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: C$748.18 million
  • Price / Sales: 0.11
  • Book Value: C($8.59) per share
  • Price / Book: -0.18
Profitability:
  • EBIDTA: C$380.7 million
  • Net Margins: -49.09%
  • Return on Assets: -8.60%
Misc:
  • Average Volume: 229,259 shs.
  • Short Ratio: 0.8
 
Frequently Asked Questions for Concordia International Corp (TSE:CXR)

What is Concordia International Corp's stock symbol?

Concordia International Corp trades on the Tornton Stock Exchange (TSX) under the ticker symbol "CXR."

How were Concordia International Corp's earnings last quarter?

Concordia International Corp (TSE:CXR) announced its quarterly earnings data on Thursday, August, 13th. The company reported $1.04 EPS for the quarter, missing analysts' consensus estimates of $1.06 by $0.02. The company earned $95.34 million during the quarter, compared to analyst estimates of $87.41 million. View Concordia International Corp's Earnings History.

When will Concordia International Corp make its next earnings announcement?

Concordia International Corp is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Concordia International Corp.

Where is Concordia International Corp's stock going? Where will Concordia International Corp's stock price be in 2017?

4 equities research analysts have issued 1-year price targets for Concordia International Corp's stock. Their predictions range from C$13.50 to C$14.00. On average, they anticipate Concordia International Corp's share price to reach C$13.75 in the next year. View Analyst Ratings for Concordia International Corp.

Who are some of Concordia International Corp's key competitors?

Who are Concordia International Corp's key executives?

Concordia International Corp's management team includes the folowing people:

  • Jordan M. Kupinsky J.D., Chairman of the Board
  • Wayne Kreppner, President, Chief Operating Officer
  • Allan Oberman, Chief Executive Officer, Director
  • David J. Price, Chief Financial Officer
  • Graeme Duncan, President - Company's International Segment
  • Arijit Mookerjee, Managing Director, Chief Financial Officer - Operations
  • Adeel Ahmad, Chief Financial Officer of AMCo
  • Francesco Tallarico, Chief Legal Officer and Secretary
  • Patrick Vink M.D., Director
  • Douglas N. Deeth, Independent Director

How do I buy Concordia International Corp stock?

Shares of Concordia International Corp and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Concordia International Corp's stock price today?

One share of Concordia International Corp stock can currently be purchased for approximately C$1.58.


MarketBeat Community Rating for Concordia International Corp (TSE CXR)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  154 (Vote Outperform)
Underperform Votes:  131 (Vote Underperform)
Total Votes:  285
MarketBeat's community ratings are surveys of what our community members think about Concordia International Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Concordia International Corp (TSE:CXR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Sell Ratings
Consensus Rating:Sell (Score: 1.00)
Consensus Price Target: C$13.75

Analysts' Ratings History for Concordia International Corp (TSE:CXR)
Show:
DateFirmActionRatingPrice TargetDetails
3/16/2017ScotiabankReiterated RatingUnderperformView Rating Details
2/9/2017TD SecuritiesDowngradeHold -> ReduceView Rating Details
12/8/2016Royal Bank Of CanadaDowngradeSector Perform -> UnderperformView Rating Details
11/7/2016Bloom BurtonDowngradeHold -> SellView Rating Details
8/15/2016Goldman Sachs Group, Inc. (The)Lower Price TargetC$34.00 -> C$17.00View Rating Details
8/15/2016CIBCDowngradeSector Perform -> UnderperformView Rating Details
3/21/2016Dundee SecuritiesLower Price TargetC$62.00 -> C$60.00View Rating Details
12/3/2015MackieDowngradeHoldView Rating Details
9/9/2015Canaccord GenuityBoost Price TargetC$95.00 -> C$100.00View Rating Details
(Data available from 8/17/2015 forward)

Earnings

Earnings History for Concordia International Corp (TSE:CXR)
Earnings by Quarter for Concordia International Corp (TSE:CXR)
Earnings History by Quarter for Concordia International Corp (TSE CXR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017        
8/13/2015Q2$1.06$1.04$87.41 million$95.34 millionViewListenView Earnings Details
8/13/2014$0.19($0.03)$24.42 million$28.49 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Concordia International Corp (TSE:CXR)
Current Year EPS Consensus Estimate: $0.80 EPS

Dividends

Dividend History by Quarter for Concordia International Corp (TSE CXR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/13/2016Quarterly$0.081.14%7/13/20167/29/20167/29/2016
4/13/2016Quarterly$0.080.95%4/13/20164/29/20164/29/2016
1/13/2016Quarterly$0.080.53%1/13/20161/29/20161/29/2016
10/13/2015Quarterly$0.080.62%10/13/201510/30/201510/30/2015
7/13/2015Quarterly$0.080.32%7/13/20157/31/20157/31/2015
4/13/2015Quarterly$0.080.35%4/13/20154/30/20154/30/2015
1/13/2015Quarterly$0.080.61%1/13/20151/31/20151/31/2015
10/10/2014Quarterly$0.080.76%10/10/201410/31/201410/31/2014
7/11/2014Quarterly$0.080.92%7/11/20147/31/20147/31/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Concordia International Corp (TSE:CXR)
Insider Trades by Quarter for Concordia International Corp (TSE:CXR)
Insider Trades by Quarter for Concordia International Corp (TSE:CXR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2017Erin Colleen O'neilDirectorSell191C$1.74C$332.34
5/16/2017Graeme Neville DuncanDirectorSell7,065C$1.91C$13,494.15
2/1/2016Mark Laurence ThompsonDirectorBuy60C$28.77C$1,726.20
11/17/2015Rochelle FuhrmannDirectorBuy2,000C$31.67C$63,340.00
11/17/2015Wayne Walter KreppnerInsiderBuy3,000C$43.67C$131,010.00
11/16/2015Mark Laurence ThompsonDirectorBuy23,150C$43.36C$1,003,702.98
10/27/2015Edward BorkowskiDirectorBuy4,000C$30.43C$121,720.00
7/23/2015Jordan KupinskyDirectorSell43,000C$103.70C$4,459,272.00
7/17/2015Wayne Walter KreppnerInsiderSell4,800C$103.00C$494,400.00
7/3/2015Jordan KupinskyDirectorSell10,800C$92.21C$995,884.20
7/2/2015Jordan KupinskyDirectorSell45,900C$92.05C$4,224,934.35
6/26/2015Robert Steven AltmanInsiderSell62,500C$93.93C$5,870,893.75
6/22/2015John-Michel HussDirectorSell5,000C$92.00C$460,000.00
6/19/2015John-Michel HussDirectorSell4,300C$90.00C$387,000.00
6/11/2015John-Michel HussDirectorSell4,500C$90.02C$405,076.50
5/27/2015Saldanha Adrian DeInsiderBuy1,000C$80.61C$80,610.00
5/19/2015Adeel AhmadInsiderSell25,000C$83.80C$2,094,890.00
10/31/2014James Christopher ReebalsDirectorSell7,500C$37.25C$279,360.75
10/30/2014James Christopher ReebalsDirectorSell7,500C$37.06C$277,926.75
10/29/2014James Christopher ReebalsDirectorSell5,000C$37.07C$185,336.50
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Concordia International Corp (TSE:CXR)
Latest Headlines for Concordia International Corp (TSE:CXR)
Source:
DateHeadline
businesswire.com logoSHAREHOLDER ALERT: Morganti Legal, PC Advises Shareholders of Concordia International Corp. of a Motion ... - Business Wire (press release)
www.businesswire.com - August 15 at 6:24 PM
finance.yahoo.com logoEdited Transcript of CXR.TO earnings conference call or presentation 11-Aug-17 12:30pm GMT
finance.yahoo.com - August 11 at 11:12 PM
americanbankingnews.com logoConcordia International Corp (TSE:CXR) Set to Announce Earnings on Friday
www.americanbankingnews.com - August 4 at 7:12 AM
finance.yahoo.com logoConcordia International Corp. :CXR-CA: Earnings Analysis: Q1, 2017 By the Numbers : August 3, 2017
finance.yahoo.com - August 3 at 7:15 PM
nasdaq.com logoShort seller Cohodes hits Canada again with latest target -Exchange Income
www.nasdaq.com - July 5 at 6:28 PM
baystreet.ca logoConcordia Shares Lead TSX Gainers on Corporate Update
www.baystreet.ca - June 22 at 10:32 AM
finance.yahoo.com logoCanadian Healthcare Stocks Under Review Concordia International, ProMetic Life Sciences, Theratechnologies, and Cardiome Pharma
finance.yahoo.com - June 9 at 8:27 AM
prnewswire.com logoConcordia International Corp. Announces Results of First CMA Stop/Go Decision - PR Newswire (press release)
www.prnewswire.com - May 31 at 9:39 PM
americanbankingnews.com logoConcordia International Corp (CXR) Given Consensus Rating of "Sell" by Analysts
www.americanbankingnews.com - May 23 at 7:48 AM
americanbankingnews.com logoConcordia International Corp (CXR) Director Graeme Neville Duncan Sells 7,065 Shares
www.americanbankingnews.com - May 17 at 8:34 PM
americanbankingnews.com logoConcordia International Corp (CXR) PT Lowered to C$0.35
www.americanbankingnews.com - May 12 at 1:02 PM
finance.yahoo.com logoEdited Transcript of CXR.TO earnings conference call or presentation 10-May-17 12:30pm GMT
finance.yahoo.com - May 10 at 9:49 PM
prnewswire.com logoConcordia International Corp. Announces Two New Appointments to ... - PR Newswire (press release)
www.prnewswire.com - May 4 at 8:02 AM
finance.yahoo.com logoConcordia International Corp. Announces Release Date for First Quarter 2017 Results
finance.yahoo.com - May 2 at 8:03 PM
americanbankingnews.com logoConcordia International Corp (CXR) Given Consensus Recommendation of "Sell" by Analysts
www.americanbankingnews.com - April 28 at 10:37 AM
finance.yahoo.com logoConcordia International Appoints David Price as Chief Financial Officer
finance.yahoo.com - April 27 at 1:48 AM
nasdaq.com logoCanadian Stocks Are Extending Recent Losses - Canadian Commentary
www.nasdaq.com - April 13 at 11:46 AM
americanbankingnews.com logoConcordia International Corp (CXR) Given Average Rating of "Sell" by Analysts
www.americanbankingnews.com - April 3 at 1:42 PM
nasdaq.com logoCanadian Stocks Are Paring Early Gains - Canadian Commentary
www.nasdaq.com - March 17 at 9:58 PM
nasdaq.com logoStocks Rally On Oil Rebound, Sober Fed -- Canadian Commentary
www.nasdaq.com - March 15 at 5:04 PM
finance.yahoo.com logoConcordia International Announces Fourth Quarter and Fiscal 2016 Results
finance.yahoo.com - March 15 at 9:47 AM
biz.yahoo.com logoQ4 2016 Concordia International Corp Earnings Release - Before Market Open
biz.yahoo.com - March 15 at 9:47 AM
nasdaq.com logoRedHill Biopharma's Co-Promotion Partner Concordia Announces ... - Nasdaq
www.nasdaq.com - March 7 at 4:34 PM
finance.yahoo.com logoConcordia International Corp. Grant of Treble Damages Further Vindicates Marketing Rights of its Donnatal® Brand - Yahoo Finance
finance.yahoo.com - March 7 at 4:34 PM
reuters.com logoProfile: Concordia International Corp (CXR.TO)
www.reuters.com - February 7 at 10:47 PM
nasdaq.com logoCanadian Stocks Are Extending Their Losses In Early Trade - Canadian Commentary - Nasdaq
www.nasdaq.com - January 31 at 5:15 PM
finance.yahoo.com logoConcordia International Corp. Announces Leadership Transition at International Segment
finance.yahoo.com - December 28 at 11:59 AM
rttnews.com logoTSX Slightly Higher, Blackberry Makes Bet On Self-driving Cars
www.rttnews.com - December 20 at 5:23 PM

Social

Chart

Concordia International Corp (CXR) Chart for Thursday, August, 17, 2017

This page was last updated on 8/17/2017 by MarketBeat.com Staff